Claudia Vivori

Ms. Claudia Vivori

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2022 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
MRMalgorzata Ewa Rogalska
Malgorzata Ewa Rogalska
CVClaudia Vivori
Claudia Vivori
JVJuan Valcárcel
Juan Valcárcel

29 October 2018 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
MGMarco Gaviraghi
Marco Gaviraghi
CVClaudia Vivori
Claudia Vivori
YSYerma Pareja Sanchez
Yerma Pareja Sanchez
FIFrancesca Invernizzi
Francesca Invernizzi
ACAngela Cattaneo
Angela Cattaneo
GTGiovanni Tonon
Giovanni Tonon

17 September 2019 in Cells
Verified
Journal Article
Open access
PDF file
MGMarco Gaviraghi
Marco Gaviraghi
CVClaudia Vivori
Claudia Vivori
GTGiovanni Tonon
Giovanni Tonon
The generation of new ribosomes is a coordinated process essential to sustain cell growth. As such, it is tightly regulated according to cell needs. As cancer cells require intense protein translation to ensure their enhanced growth rate, they exploit various mechanisms to boost ribosome biogenesis. In this review, we will summarize how oncogenes and tumor suppressors modulate the biosynthesis of the RNA component of ribosomes, starting from the description of well-characterized pathways that converge on ribosomal RNA transcription while including novel insights that reveal unexpected regulatory networks hacked by cancer cells to unleash ribosome production.

9 February 2023 in RNA
Verified
Journal Article
Open access
PDF file
IEImke Ensinck
Imke Ensinck
Theodora SideriTheodora Sideri
Theodora Sideri
MMMiha Modic
Miha Modic
CCCharlotte Capitanchik
Charlotte Capitanchik
CVClaudia Vivori
Claudia Vivori
FWFolkert J. van Werven
Folkert J. van Werven
N6-methyladenosine (m6A) is a widely studied and abundant RNA modification. The m6A mark regulates the fate of RNAs in various ways, which in turn drives changes in cell physiology, development, and disease pathology. Over the last decade, numerous methods have been developed to map and quantify m6A sites genome-wide through deep sequencing. Alternatively, m6A levels can be quantified from a population of RNAs using techniques such as liquid chromatography-mass spectrometry or thin layer chromatography. However, many methods for quantifying m6A levels involve extensive protocols and specialized data analysis, and often only a few samples can be handled in a single experiment. Here, we developed a simple method for determining relative m6A levels in mRNA populations from various sources based on an enzyme-linked immunosorbent-based assay (m6A-ELISA). We have optimized various steps of m6A-ELISA, such as sample preparation and the background signal resulting from the primary antibody. We validated the method using mRNA populations from budding yeast and mouse embryonic stem cells. The full protocol takes less than a day, requiring only 25 ng of mRNA. The m6A-ELISA protocol is quick, cost-effective, and scalable, making it a valuable tool for determining relative m6A levels in samples from various sources that could be adapted to detect other mRNA modifications.

3 June 2021 in Genome Biology
Verified
Journal Article
Open access
PDF file
CVClaudia Vivori
Claudia Vivori
PPPanagiotis Papasaikas
Panagiotis Papasaikas
RSRalph Stadhouders
Ralph Stadhouders
BSBruno Di Stefano
Bruno Di Stefano
ARAnna Ribó Rubio
Anna Ribó Rubio
JVJuan Valcárcel
Juan Valcárcel
Background: Somatic cell reprogramming is the process that allows differentiated cells to revert to a pluripotent state. In contrast to the extensively studied rewiring of epigenetic and transcriptional programs required for reprogramming, the dynamics of post-transcriptional changes and their associated regulatory mechanisms remain poorly understood. Here we study the dynamics of alternative splicing changes occurring during efficient reprogramming of mouse B cells into induced pluripotent stem (iPS) cells and compare them to those occurring during reprogramming of mouse embryonic fibroblasts.Results: We observe a significant overlap between alternative splicing changes detected in the two reprogramming systems, which are generally uncoupled from changes in transcriptional levels. Correlation between gene expression of potential regulators and specific clusters of alternative splicing changes enables the identification and subsequent validation of CPSF3 and hnRNP UL1 as facilitators, and TIA1 as repressor of mouse embryonic fibroblasts reprogramming. We further find that these RNA-binding proteins control partially overlapping programs of splicing regulation, involving genes relevant for developmental and morphogenetic processes.Conclusions: Our results reveal common programs of splicing regulation during reprogramming of different cell types and identify three novel regulators of this process and their targets.

20 September 2021 in RNA
Verified
Journal Article
Open access
PDF file
EMElena Martín
Elena Martín
CVClaudia Vivori
Claudia Vivori
MRMalgorzata Rogalska
Malgorzata Rogalska
JHJorge Herrero-Vicente
Jorge Herrero-Vicente
JVJuan Valcárcel
Juan Valcárcel
The regulation of pre-mRNA processing has important consequences for cell division and the control of cancer cell proliferation, but the underlying molecular mechanisms remain poorly understood. We report that three splicing factors, SPF45, SR140, and CHERP, form a tight physical and functionally coherent complex that regulates a variety of alternative splicing events, frequently by repressing short exons flanked by suboptimal 3′ splice sites. These comprise alternative exons embedded in genes with important functions in cell-cycle progression, including the G2/M key regulator FOXM1 and the spindle regulator SPDL1. Knockdown of either of the three factors leads to G2/M arrest and to enhanced apoptosis in HeLa cells. Promoting the changes inFOXM1orSPDL1splicing induced by SPF45/SR140/CHERP knockdown partially recapitulates the effects on cell growth, arguing that the complex orchestrates a program of alternative splicing necessary for efficient cell proliferation.